tiprankstipranks
Trending News
More News >

Clover Biopharmaceuticals’ Resolutions Pass with Strong Support

Clover Biopharmaceuticals’ Resolutions Pass with Strong Support

Clover Biopharmaceuticals Ltd. (HK:2197) has released an update.

Don’t Miss TipRanks’ Half-Year Sale

Clover Biopharmaceuticals, Ltd. held a successful Annual General Meeting on June 20, 2024, where all resolutions proposed were overwhelmingly passed with nearly unanimous support. Key approvals included the adoption of audited financials, re-election of directors, and authorization for share dealings and auditor remuneration. The meeting also resulted in the adoption of new amendments to the company’s memorandum and articles of association.

For further insights into HK:2197 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1